The strong genetic evidence linking CARD14 to psoriasis (https://platform.opentargets.org/disease/EFO_0000676/associations), combined with data from loss-of-function and gain-of-function Card14 mutants in mice suggests that pharmacologic inhibition of CARD14 signalling will ameliorate psoriasis [16]. This evidence concerns the gene CARD14 and psoriasis.